Article

Ophthalmology part of Haiti relief efforts

Ophthalmologists, ophthalmic organizations, and companies operating in the ophthalmology arena are contributing to efforts to help Haiti respond to and recover from the earthquake that occurred in January.

Port-au-Prince, Haiti-Ophthalmologists, ophthalmic organizations, and companies operating in the ophthalmology arena are contributing to efforts to help Haiti respond to and recover from the earthquake that occurred in January.

For instance, Abbott has pledged $2.5 million in grant funding and donations of pharmaceutical and nutritional products to humanitarian aid organizations. Initial support from the Abbott Fund included $150,000 in grants to four humanitarian aid partners: American Red Cross, CARE, Catholic Medical Mission Board, and Partners In Health.

Abbott also is working with AmeriCares, Catholic Medical Mission Board, Direct Relief International, Heart to Heart International, MAP International, Project Hope, and additional organizations to identify and distribute nutritional and pharmaceutical products. In addition, almost 30 Abbott volunteers in the Dallas area are planning to help the American Red Cross with fundraising and other activities to support the efforts of the organization in Haiti.

"A tragedy of this magnitude requires support from the global community, and it is our hope that our contribution, along with all of the aid coming in from around the world, will help the people of Haiti begin the rebuilding and healing process," said Joe Adachi, president and chief executive officer, Canon U.S.A. Inc.

The American Academy of Ophthalmology has posted information about ophthalmologists' volunteer efforts, news from various organizations participating in relief efforts, and information about how people can donate or volunteer on its Web site at http://www.aao.org/haiti/reports.cfm

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.